Foresite Capital Management V, LLC Diversified Active

CIK: 0001792206 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $135,028 (100.0% shares, 0.0% debt)

Holdings (12)

— Kinnate Biopharma Inc. 25.8%

Value ($000) $34,808 Shares 875,001 Est. Cost $39.78 Unrealized —

ALXO ALX Oncology Holdings Inc. 20.4%

Value ($000) $27,584 Shares 320,000 Est. Cost $60.15 Unrealized 0.0%

RLAY Relay Therapeutics, Inc. 12.3%

Value ($000) $16,624 Shares 400,000 Est. Cost $45.21 Unrealized 0.0%

NRIX Nurix Therapeutics, Inc. 11.0%

Value ($000) $14,846 Shares 451,522 Est. Cost $33.14 Unrealized 0.0%

— Oaktree Acquisition Corp. 9.4%

Value ($000) $12,723 Shares 871,422 Est. Cost $14.60 Unrealized —

— Population Health Investment Co., Inc. 7.4%

Value ($000) $10,032 Shares 960,000 Est. Cost $10.45 Unrealized —

— Therapeutics Acquisition Corp 3.6%

Value ($000) $4,872 Shares 350,000 Est. Cost $13.92 Unrealized —

— BCTG Acquisition Corp. 3.4%

Value ($000) $4,576 Shares 400,000 Est. Cost $11.44 Unrealized —

— LifeSci Acquisition II Corp. 3.2%

Value ($000) $4,268 Shares 400,000 Est. Cost $10.67 Unrealized —

MLTX Helix Acquisition Corp. 2.1%

Value ($000) $2,843 Shares 250,000 Est. Cost $11.37 Unrealized —

— Consonance-HFW Acquisition Corp. 0.8%

Value ($000) $1,047 Shares 100,000 Est. Cost $10.47 Unrealized —

ABCL Abcellera Biologics Inc. 0.6%

Value ($000) $805 Shares 20,000 Est. Cost $45.73 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Kinnate Biopharma Inc.	875,001	$34,808	25.8%	$39.78	—	COM	49705R105
ALXO	ALX Oncology Holdings Inc.	320,000	$27,584	20.4%	$60.15	0.0%	COM	00166B105
RLAY	Relay Therapeutics, Inc.	400,000	$16,624	12.3%	$45.21	0.0%	COM	75943R102
NRIX	Nurix Therapeutics, Inc.	451,522	$14,846	11.0%	$33.14	0.0%	COM	67080M103
—	Oaktree Acquisition Corp.	871,422	$12,723	9.4%	$14.60	—	SHS CL A	G67145105
—	Population Health Investment Co., Inc.	960,000	$10,032	7.4%	$10.45	—	UNIT	G71716123
—	Therapeutics Acquisition Corp	350,000	$4,872	3.6%	$13.92	—	COM CL A	88339T103
—	BCTG Acquisition Corp.	400,000	$4,576	3.4%	$11.44	—	COM	05492W103
—	LifeSci Acquisition II Corp.	400,000	$4,268	3.2%	$10.67	—	COM	53229E103
MLTX	Helix Acquisition Corp.	250,000	$2,843	2.1%	$11.37	—	COM CL A	G4444C102
—	Consonance-HFW Acquisition Corp.	100,000	$1,047	0.8%	$10.47	—	UNIT	0G244M129
ABCL	Abcellera Biologics Inc.	20,000	$805	0.6%	$45.73	0.0%	COM	00288U106